These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 3399664
21. Oral zinc sulphate treatment in Wilson's disease. Pasqualicchio M, Marrella M, Moretti U, Velo GP, Deganello A, Tomelleri G, Milanino R. Acta Physiol Hung; 1990; 75 Suppl():233-4. PubMed ID: 2371874 [No Abstract] [Full Text] [Related]
22. Neurological abnormalities in Wilson's disease are reversible. Lingam S, Wilson J, Nazer H, Mowat AP. Neuropediatrics; 1987 Feb; 18(1):11-2. PubMed ID: 3561699 [Abstract] [Full Text] [Related]
23. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper. Brewer GJ, Hill GM, Dick RD, Nostrant TT, Sams JS, Wells JJ, Prasad AS. J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199 [Abstract] [Full Text] [Related]
27. Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease. Pasqualicchio M, Milanino R, Marrella M, Moretti U, Tomelleri G, Velo GP. Pharmacol Res; 1989 Sep; 21 Suppl 1():151-2. PubMed ID: 2633173 [No Abstract] [Full Text] [Related]
28. Wilson's disease: from the liver to the brain. Taylor R, Dhawan A. Nurs Times; 1989 Sep; 97(30):38-40. PubMed ID: 11957950 [No Abstract] [Full Text] [Related]
29. Zinc therapy as the initial treatment for Wilson's disease. Hoogenraad TU, Van Hattum J. Arch Neurol; 1988 Apr; 45(4):373-4. PubMed ID: 3355392 [No Abstract] [Full Text] [Related]
30. [Treatment of Wilson's disease using triethylenetetramine dihydrochloride (TETA)]. Hauftová D, Körbel J, Jancík F, Kuhr I, Ferenc M. Cesk Gastroenterol Vyz; 1978 Dec; 32(8):538-9. PubMed ID: 737791 [No Abstract] [Full Text] [Related]
31. Drug therapy in Wilson's disease. Reed K. J Am Optom Assoc; 1988 Jun; 59(6):438. PubMed ID: 3403885 [No Abstract] [Full Text] [Related]
35. Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers. Hoogenraad TU, Rothuizen J. Lancet; 1986 Jul 19; 2(8499):170. PubMed ID: 2873435 [No Abstract] [Full Text] [Related]
36. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance. Hill GM, Brewer GJ, Juni JE, Prasad AS, Dick RD. Am J Med Sci; 1986 Dec 19; 292(6):344-9. PubMed ID: 3799705 [Abstract] [Full Text] [Related]
38. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. Scheinberg IH, Jaffe ME, Sternlieb I. N Engl J Med; 1987 Jul 23; 317(4):209-13. PubMed ID: 3600712 [Abstract] [Full Text] [Related]
39. [Advances in the study of hepatolenticular degeneration]. Liu DK, Li NZ, Chen XZ, Yang YF. Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug 23; 18(4):248-51. PubMed ID: 3908020 [No Abstract] [Full Text] [Related]
40. Oral zinc sulphate for Wilson's disease. Van Caillie-Bertrand M, Degenhart HJ, Visser HK, Sinaasappel M, Bouquet J. Arch Dis Child; 1985 Jul 23; 60(7):656-9. PubMed ID: 4026362 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]